NCT02474134View on ClinicalTrials.gov

Comparison Study of PF530 and Betaferon in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (PF530, Betaferon)

Single subcutaneous administration

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfenex, Inc

INDUSTRY